http://rdf.ncbi.nlm.nih.gov/pubchem/patent/YU-40799-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27a71ddaaa2f5a8c228fc6cb3f3b3098
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4965
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4965
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-26
filingDate 1998-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_feb7ccfa1f3b3c9067ce43b43ad824bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6511e444ee5f63ff219e9f3e10e688b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9d9b19e6395043a258fee2e3543a071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ae24eed4c8de401a92207a99724e0ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae09a022308a15eff2b361eb531935ec
publicationDate 2001-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber YU-40799-A
titleOfInvention PYRAZINE UNITS
abstract A compound of formula (I) wherein R 1 is selected from the group consisting of phenyl substituted with one or more halogen atoms, naphthyl and naphthyl substituted with one or more halogen atoms; R2 is selected from the group consisting of -NH2 and -NHC (= O) Ra; R3 is selected from the group consisting of: -NRbRc, -NHC (= O) Ra and hydrogen; R4 is selected from the group consisting of: hydrogen, C14alkyl, C1-4alkyl substituted with one or more halogen atoms, -CN, -CH2OH, -CH2ORd and -CH2S (O) xRd; wherein R a is C 1-4 alkyl or C 3-7 cycloalkyl, and R b and R c, which may be the same or different, are selected from: hydrogen and C 1-4 alkyl, or together with the nitrogen atom to which they are attached, form a 6-membered heterocycle containing nitrogen, and that heterocycle may still be substituted with one or more C1-4alkyl; Rd is selected from C1-4alkyl or C1-4alkyl substituted with one or more halogen atoms; x is an integer one or two; and pharmaceutically acceptable derivatives thereof; with the proviso that R1 does not represent (a) when R2 is -NH2 and when both R3 and R4 are hydrogen.
priorityDate 1997-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457444288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783

Total number of triples: 37.